First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

Recruiting · NCT05099172 · Registry updated 2026-08-12

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)	Advanced Non-small Cell Lung Cancer; EGFR Mutation; HER2 Mutation	Recruiting	Phase 1 / Phase 2	2026-08-12		NCT05099172

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bayer	178

92 results · Page 1 of 4

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aichi Cancer Center Hospital	Nagoya	Japan	30
AP-HM - Hopital de la Timone - Centre d'Essais en Cancerologie	Marseille	France	1
Asan Medical Center \| Oncology	Seoul	South Korea	2
AZ Delta \| Clinical Trial Center - Pneumology	Roeselare	Belgium	2
Azienda Ospedaliero Universitaria Parma - SC Oncologia Medica	Parma	Italy	1
Azienda Ospedaliero-Universitaria San Luigi Gonzaga - Oncologia Medica	Orbassano	Italy	2
Banner MD Anderson Cancer Center at Banner Gateway Medical Center	Gilbert	United States	1
Beijing Cancer Hospital - Oncology Department	Beijing	China	6
Beijing Hospital	Beijing	China	33
Brigette Harris Cancer Pavilion at Henry Ford Cancer Center - Detroit	Detroit	United States	3
Centro di Riferimento Oncologico di Aviano - Oncologia Medica e dei Tumori Immuno-Correlati	Aviano	Italy	3
Centro Ricerche Cliniche Di Verona S.r.l. - Oncologia	Verona	Italy	2
Chaim Sheba Medical Center	Ramat Gan	Israel	8
Chang Gung Memorial Hospital at Linkou	Taoyuan	Taiwan	4
Chi-Mei Medical Center, Liouyine	Tainan	Taiwan	2
Chung Shan Medical University Hospital	Taichung	Taiwan	5
Chungbuk National University Hospital \| Hematology and Oncology	Chungcheongbuk-do	South Korea	2
City of Hope - Duarte Cancer Center	Duarte	United States	7
Curie Oncology \| Mount Elizabeth Novena	Singapore	Singapore	1
Dana-Farber Cancer Institute - Oncology Department	Boston	United States	4
Emory Winship Cancer Institute	Atlanta	United States	29
Erasmus University Medical Center \| Research Department - Lung Diseases	Rotterdam	Netherlands	1
Fondazione IRCCS Istituto Nazionale dei Tumori - S. C. Oncologia Medica 1	Milan	Italy	4
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOC Fase I	Roma	Italy	3
Fujian Cancer Hospital	Fuzhou	China	109

First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

Clinical trials

Organizations

Research sites